Immunological aspects of demyelinating diseases

Annual Review of Immunology

Volumn 10, Issue , 1992, Pages 153-187

  Martin, Roland ^a   McFarland, Henry F ^a   McFarlin, Dale E ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

demyelinating disease; multiple sclerosis; myelin basic protein

Indexed keywords

MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL TISSUE; AUTOIMMUNITY; DEMYELINATING DISEASE; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; T LYMPHOCYTE;

EID: 0026645658     PISSN: 03013782     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.iy.10.040192.001101     Document Type: Review

References (171)

1. Adams, R. D., Kubik, C. S. 1952. The morbid anatomy of the demyelinative diseases. Am. J. Med. 12: 510-46
2. Peters, A. 1960. The structure of myelin sheaths in the central nervous system of xenopus laevis (Daudin). J. Biophy. Biochem. Cytol. 7: 121-26
3. Green, B. G. 1954. The formation from the Schwann cell surface of myelin in peripheral nerves of chick embryos. Exp. Cell Res. 7: 558-62
4. Bunge, M. B., Bunge, R. P., Pappas, G. D. 1962. Electron microscopic demonstrations of connection between glia and myelin sheaths in the development mammalian brain. J. Cell Biol. 12: 448-53
5. Waxman, S. G. 1985. Structure and function of the myelinated fiber. In Handbook of Clinical Neurology, Demyelinaling Diseases, ed. J. C. Koetsier, 3(47): 1-28. Amsterdam/New York: Elsevier Sci.
6. Quarles, R. H., Morell, P., McFarlin, D. E. 1989. Diseases involving myelin. In Basic Neurochemistry, ed. G. Siegel, B. Agranoff, R. W. Albers, P. Molinoff, pp. 697-713. New York: Raven. 4th ed.
7. Adams, C. W. 1989. A colour atlas of multiple sclerosis and other myelin disorders. London: Wolfe Med.
8. Suzuki, K. 1989. Genetic disorders of lipid, glycoprotein, and mucopolysaccharide metabolism. In Basic Neurochemistry, ed. G. Siegel, B. Agranoff, R. W. Albers, P. Molinoff, pp. 715-32. New York: Raven. 4th ed.
9. Moser, H. W., Moser, A. E., Singh, I., O'Neil, B. P. 1984. Adrenoleuko dystrophy - Survey of 303 cases: biochemistry, diagnosis and therapy. Ann. Neurol. 16: 628-41
10. Bernheimer, H., Budka, H., Muller, P. 1983. Brain tissue immunoglobulins in adrenoleukodystrophy: a comparison with multiple sclerosis and systemic lupus erythematosus. Acta Neuropath. 59: 95-102
11. Ludwin, S. K. 1978. CNS demyelination and remyelination in the mouse. An ultrastructural study of cuprizone toxicity. Lab. Invest. 39: 597-612
12. Smith, M. L., Benjamin, J. A. 1984. Model systems for the perturbations of myelin metabolism. In Myelin, ed. P. Morell, pp. 441-87. New York: Plenum
13. Johnson, R. T. 1985. Viral aspects of multiple sclerosis. In Handbook of Clinical Neurology, Demyelinating Diseases, ed. J. C. Koetsier, 3(47): 319-36. Amsterdam/New York: Elsevier Sci.
14. Levy, R. M., Bredeson, D. E., Rosenblum, M. L. 1988. Opportunistic central nervous system pathology in patients with AIDS. Ann. Neurol. 23(Suppl. 1): 7-12
15. Vernant, J. C., Maurs, L., Gessain, A., Barin, F., Gout, O., Delaporte, J. M., Sanhadji, K., Buisson, G. 1987. Endemic tropical spastic paraparesis associated with HTLV-I: a clinical and seroepidemiological study of 25 cases. Ann. Neurol. 21: 123-30
16. Osame, M., Matsumoto, M., Usuku, K. 1987. Chronic-progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type 1 and adult T-cell leukemia-like cells. Ann. Neurol. 21: 117-22
17. Jacobson, S., Gupta, A., Mattson, D. H., Mingioli, E. S., McFarlin, D. E. 1990. Immunological studies in tropical spastic paraparesis. Ann. Neurol. 27: 149-56
18. Jacobson, S., Shida, H., McFarlin, D. E., Fauci, A. S., Koenig, S. 1990. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245-48
19. Johnson, R. T., Griffin, D. E., Hirsch, J. S., Wolinsky, J. S., Rodenbeck, S., Lindo De Soriano, I., Vaisberg, A. 1984. Measles encephalomyelitis clinical and immunological studies. N. Engl. J. Med. 310: 137-41
20. Haase, A. T. 1986. Pathogenesis of lentivirus infections. Nature 322: 130-36
21. Narayan, O., Sheffer, D., Clements, J. E. 1985. Restricted replication of lentiviruses. J. Exp. Med. 162: 1954-69
22. Chamorro, M., Aubert, C., Brahic, M. 1986. Demyelinating lesions due to Theiler's virus are associated with central nervous system infection. J. Virol. 57: 992-97
23. Clatch, R. J., Lipton, H. L., Miller, S. D. 1986. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating diseases: correlation with clinical signs. J. Immunol. 136: 920-27
24. Lipton, H. L., Dal Canto, M. C. 1976. Theiler's virus induced demyelination-prevention by immunosuppression. Science 192: 62-64
25. Yamada, M., Zurbriggen, A., Fujinami, R. S. 1990. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J. Exp. Med. 171: 1893-1907
26. Watanabe, R., Wege, H., ter Meulen, V. 1983. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature 305: 150-52
27. Liebert, U. G., Linington, C., ter Meulen, V. 1978. Induction of autoimmune reactions to myelin basic protein in measles virus encephalitis in Lewis rats. J. Neuroimmunol. 17: 103-18
28. Remlinger, J. 1905. Accidents paralytiques au cours du traitment antirabique. Ann. Inst. Pasteur 19: 625-46
29. Rivers, T. M., Sprunt, D. H., Berry, G. P. 1933. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J. Exp. Med. 58: 39-53
30. Fritz, R., McFarlin, D. E. 1989. Encephalitogenic epitopes of myelin basic protein. In Chem. Immunol., ed. E. Sercarz, 46: 101-25. Basel: Karger
31. Kabat, E. A., Wolf, A., Bezer, A. E. 1946. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of brain tissue with adjuvants. Science 104: 362-63
32. Martenson, R. E. 1984. Myelin basic protein speciation. In Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis, ed. E. C. Alvord, Jr., pp. 146-511. New York: Liss
33. Kamholz, J., de Ferra, F., Puckett, C., Lazzarini, R. 1986. Identification of three forms of human myelin basic protein by cDNA cloning. Proc. Natl. Acad. Sci. USA 83: 4962-66
34. Fritz, R. B., Skeen, M. J., Chou, C.-H. J., Zamvil, S. S. 1990. Localization of an encephalitogenic epitope for the SJL mouse in the N-terminal region of myelin basic protein. J. Neuroimmunol. 26: 239-43
35. Tuohy, V. K., Sobel, R. A., Lees, M. B. 1988. Myelin proteolipid protein-induced experimental allergic encephalomyelitis: variations of disease expression in different strains of mice. J. Immunol. 140: 1868-73
36. Tuohy, V. K., Lu, Z., Sobel, R. A., Laursen, R. A., Lees, M. B. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142: 1523-27
37. Quarles, R. H. 1988. Myelin-associated glycoprotein: functional and clinical aspects. In Neurological Research, Vol. II: Neuronal and Glial Proteins Structures, Function, and Clinical Application, ed. P. J. Marangos, I. Campbell, R. M. Cohen, pp. 295-320. New York: Academic
38. Le Bar, R., Lubetski, C., Vincent, C., Lombrail, P., Boutry, J. M. 1986. The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin. Exp. Immunol. 66: 423-43
39. Cohen, I. R. 1981. Multiple sclerosis-like disease induced in rabbits by immunization with brain gangliosides. Isr. J. Med. Sci. 17: 711-14
40. Levine, S., Wenk, E. J. 1965. A hyper-acute form of allergic encephalomyelitis. Am. J. Pathol. 47: 61-88
41. Bernard, C. C. A., Carnegie, P. R. 1973. Experimental allergic encephalomyelitis in mice: immune response to mouse spinal cord and myelin basic protein. J. Immunol. 114: 1537-40
42. Raine, C. S. 1983. Multiple sclerosis and chronic relapsing EAE: comparative ultrastructural neuropathology. In Multiple Sclerosis, ed. J. F. Hallpike, C. W. M. Adams, W. W. Tourtellotte, pp. 413-78. Baltimore: Williams & Wilkins
43. Moore, G. W. R., Traugott, U., Farooq, M., Norton, W. T., Raine, C. S. 1984. Experimental autoimmune encephalomyelitis. A generation of demyelination by different myelin lipids. Lab. Invest. 51: 416-24
44. Paterson, P. Y. 1960. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J. Exp. Med. 111: 119-33
45. Stone, S. H. 1961. Transfer of allergic encephalomyelitis by lymph node cells in inbred guinea pigs. Science 134: 619-21
46. Panitch, H. S., McFarlin, D. E. 1977. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A. J. Immunol. 119: 1134-37
47. Richert, J. R., Driscoll, B. G., Kies, M. W., Alvord, E. C. Jr. 1979. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen. J. Immunol. 122: 494-96
48. Ben-Nun, A., Wekerle, H., Cohen, I. R. 1981. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11: 195-99
49. Pettinelli, C. B., McFarlin, D. E. 1981. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vivo activation of lymph node cells by myelin basic protein: requirement for Lyt-1+2- T lymphocytes. J. Immunol. 127: 1420-23
50. Steinman, L., Rosenbaum, J., Sriram, S., McDevitt, H. O. 1981. In vivo effects of antibodies to immune response gene products: Prevention of experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. USA 78: 7111-14
51. Aharoni, R., Teitelbaum, D., Arnon, R., Purl, J. 1991. Immunomodulation of experimental allergic encephalitis by antibodies to antigen Ia complex. Nature 351: 147-50
52. Sakai, K., Zamvil, S. S., Mitchell, D. J., Hodgkinson, S., Rothbard, J. B., Steinman, L. 1989. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. Proc. Natl. Acad. Sci. USA 86: 9470-74
53. Wraith, D. C., Smilek, D. E., Mitchell, D. J., Steinman, L., McDevitt, H. O. 1989. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59: 247-55
54. Lamont, A. G., Sette, A., Fujinami, R., Colon, S. M., Miles, C., Grey, H. M. 1990. Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for Ia molecules. J. Immunol. 145: 1687-93
55. Teitelbaum, D., Aharoni, R., Arnon, R., Sela, M. 1988. Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop-1. Proc. Natl. Acad. Sci. USA 85: 9724-28
56. Brostoff, S. W., Mason, D. W. 1984. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J. Immunol. 133: 1938-42
57. Waldor, M. K., Sriram, S., Hardy, R., Herzenberg, L. A., Herzenberg, L. A., Lanier, L., Lim, M., Steinman, L. 1985. Reversal of experimental allergic encephalomyelitis with a monoclonal antibody to a T cell subset marker (L3T4). Science 227: 415-17
58. Kennedy, M. K., Tan, L.-J., Dal Canto, M. C., Miller, S. D. 1990. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. J. Immunol. 145: 117-26
59. Zamvil, S. S., Steinman, L. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8: 579-621
60. Acha-Orbea, H., Mitchell, D. J., Timmermann, L., Wraith, D. C., Tausch, G. S. 1988. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54: 263-73
61. Urban, J. L., Kumar, V., Kono, D. H., Gomez, C., Horvath, S. J., Clayton, J., Ando, D. L., Sercarz, E. E., Hood, L. 1988. Restricted use of the T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54: 577-92
62. Ben-Nun, A., Wekerle, H., Cohen, I. R. 1981. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 293: 60-61
63. Burns, F. R., Li, X., Shen, N., Offner, H., Chou, Y. K., Vandenbark, A., Heber-Katz, E. 1989. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Vα and Vβ chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J. Exp. Med. 169: 27-39
64. Vandenbark, A. A., Hashim, G., Offner, H. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341: 541-44
65. Offner, H., Hashim, G. A., Vandenbark, A. A. 1990. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251: 430-32
66. Claverie, J.-M., Prochnicka-Chalufour, A., Bougueleret, L. 1989. Implications of a Fab-like structure for the T-cell receptor. Immunol. Today 10: 10-14
67. Howell, M. D., Winters, S. T., Olee, T., Powell, H. C., Carlo, D. J., Brostoff, S. W. 1989. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246: 668-70
68. Bitar, D. M., Whitacre, C. C. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. Cell. Immunol. 112: 364-70
69. Higgins, P. J., Weiner, H. L. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140: 440-45
70. Whitacre, C. C., Fuller, K. A., Gienapp, I. E. 1991. Oral tolerance in experimental autoimmune encephalomyelitis (EAE): evidence for clonal anergy. FASEB J. 5: A1678
71. 1. J. Immunol. 146: 3012-17
72. Harris, J. O., Frank, J. O., Patronas, N., McFarlin, D. E., McFarland, H. F. 1991. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implication for clinical trials and natural history. Ann. Neurol. 29: 548-55
73. Prineas, J. W. 1985. The neuropathology of multiple sclerosis. In Handbook of Clinical Neurology, Demyelinating Diseases, ed. P. J. Vinken, G. W. Bruyn, H. L., Klawans, J. C. Koetsier, 3(47)47: 213-57. Amsterdam/New York: Elsevier Sci.
74. Hauser, S. L., Bhan, A. K., Gilles, F. 1986. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesion. Ann. Neurol. 19: 578-87
75. Booss, J., Esiri, M. M., Tourtellotte, W. W. 1983. Immunohistochemical analysis of T-lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62: 19-32
76. Traugott, U., Reinherz, E. L., Raine, C. S. 1983. Multiple sclerosis: distribution of T-cell subsets within active chronic lesions. Science 219: 308-10
77. Hofman, F. M., vonHanwehr, R. I., Dinarello, C. A. 1986. Immunoregulatory molecules and IL2 receptors identified in multiple sclerosis brain. J. Immunol. 136: 3239-45
78. Traugott, U., Scheinberg, L. C., Raine, C. S. 1985. On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J. Neuroimmunol. 8: 1-14
79. Sanders, M. E., Koski, C. L., Robbins, D. 1986. Activated terminal complement in cerebrospinal fluid in Guillain-Barre syndrome and multiple sclerosis. J. Immunol. 136: 4456-59
80. Selmaj, K., Brosnan, C. F., Raine, C. S. 1991. Colocalization of lymphocytes bearing γδ T-cell receptor and hsp65+ oligodendrocytes in multiple sclerosis. Proc. Natl. Acad. Sci. USA 88: 6452-56
81. Panitch, H. S., Hirsch, R. L., Schindler, J., Johnson, K. P. 1987. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37: 1097-1102
82. Reder, A. T., Arnason, B. G. W. 1985. Immunology of multiple sclerosis. In Handbook of Clinical Neurology, ed. J. C. Koetsier, 3(47): 337-95. Amsterdam/New York: Elsevier Sci.
83. Kabat, E. A., Freedman, D. A., Murray, J. P., Knaub, V. 1950. A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of one hundred cases of multiple sclerosis and in other diseases. Am. J. Med. Sci. 219: 55-64
84. Tourtellotte, W. W. 1985. The cerebrospinal fluid in multiple sclerosis. In Handbook of Clinical Neurology, ed. P. J. Vinken, G. W. Bruyn, H. L. Klawans, J. C. Koetsier, 3(47): 79-130. Amsterdam/New York: Elsevier Sci.
85. Lowenthal, A., Van Sande, M., Karcher, D. 1960. The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF G-globulins. J. Neurochem. 6: 51-56
86. Martin, R., Martens, U., Sticht-Groh, V., Dorries, R., Kruger, H. 1988. Persistent intrathecal secretion of oligoclonal, Borrelia burgdorferi-specific IgG in chronic meningo-radiculo-myelitis. J. Neurol. 235: 229-33
87. Antel, J. P., Arnason, B. G. W. 1979. Suppressor cell function in multiple sclerosis-correlation with clinical disease activity. Ann. Neurol. 5: 338-42
88. Morimoto, C. M., Hafler, D. A., Weiner, H. L., Letvin, N., Hagan, M., Daley, T., Schlossman, S. F. 1987. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. N. Engl. J. Med. 316: 67-72
89. Jacobson, S. J., Flerlage, M. L., McFarland, H. F. 1985. Impaired measles virus-specific cytotoxic T-cell response in multiple sclerosis. J. Exp. Med. 162: 839-50
90. Waksman, B. H., Reynolds, W. E. 1984. Minireview: multiple sclerosis as a disease of immune regulation. Proc. Soc. Exp. Biol. Med. 175: 282-94
91. Palffy, G. 1982. MS in Hungary, including Gypsy population. In Multiple Sclerosis East and West, ed: Y. Kuroiwa, L. T. Kurland, pp. 149-57. Basel: Karger
92. Sadovnick, A. D., Baird, P. A., Ward, R. H. 1988. Multiple sclerosis: updated risks for relatives. Am. J. Med. Genet. 29: 533-41
93. Ebers, G. C. 1983. Genetic factors in multiple sclerosis. Neurol. Clin. 1: 645-54
94. McFarland, H. F., Greenstein, J. I., McFarlin, D. E., Eldridge, R., Xu, X., Krebs, H. 1985. Family and twin studies in multiple sclerosis. Ann. N.Y. Acad. Sci. 436: 118-24
95. Ebers, G. C., Buhman, D. E., Sadovnick, A. D., Paty, D. W., Warren, S., Hader, W., Murray, T. J., Seland, T. P., Duquette, P., Grey, T., Nelson, R., Nicolle, M., Brunei, D. 1986. A population-based study of multiple sclerosis in twins. N. Engl. J. Med. 315: 1638-42
96. McCombe, P. A., Clark, P Frith, J. A., Hammond, S. R., Stewart, G. J., Pollard, J. D., McLeod, J. G. 1985. Alpha-1 antitrypsin phenotypes in demyelinating diseases: an association between demyelinating disease and the allele PiM3. Ann. Neurol. 18: 514-16
97. Pandey, J. P., Goust, J. M., Salier, J. P., Fundenberg, H. H. 1981. Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis. J. Clin. Invest. 67: 1797-1800
98. Boylan, K. B., Takahashi, N., Paty, D. W., Sadovnick, A. D., Diamond, M., Hood, L. E., Prusiner, S. B. 1990. DNA length polymorphism 5′ to the myelin basic protein gene is associated with multiple sclerosis. Ann. Neurol. 27: 291-97
99. Bertram, J., Kuwert, E. 1982. HLA antigen frequencies in multiple sclerosis. Eur. J. Neurol. 7: 74-79
100. Tiwari, J. L., Terasaki, P. I. 1985. In HLA and Disease Associations 152-67 pp. New York: Springer-Verlag
101. Bodmer, J. G., Marsh, S. G. E., Parham, P., Erlich, H. A., Albert, E., Bodmer, W. F., Dupont, B., Mach, B., Mayr, W. R., Sasazuki, T., Schreuder, G. M. Th., Strominger, J. L., Svejgaard, S., Terasaki, P. I. 1990. Nomenclature for factors of the HLA system. Human Immunol. 28: 326-42
102. Marrosu, H. G., Muntoni, F., Murru, M. R., Spinicci, G., Pischelda, M. P., Goddi, F., Cossu, P., Pirastu, M. 1988. Sardinian multiple sclerosis is associated with HLA-DR4: a serological and molecular analysis. Neurology 38: 1749-53
103. Kurdi, A., Ayesh, I., Addallat, A., Maayta, U., McDonald, W. I., Compston, D. A. S., Batchelor, J. R. 1977. Different B-lymphocyte alloantigens associated with multiple sclerosis in Arabs and Northern Europeans. Lancet i: 1123-25
104. Naito, S., Kuroiwa, Y., Itoyama, T., Tsubaki, T., Horikawa, A., Sasazuki, T., Noguchi, S., Ohtsuki, S., Tokumi, H., Miyatake, T., Takahata, N., Kawanami, S., McMichael, A. J. 1978. HLA and Japanese MS. Tissue Antigens 12: 19-24
105. Gorodezky, C., Najera, R., Rangel, B. E., Castro, L. E., Flores, J., Velazquez, G., Granados, J., Sotelo, J. 1986. Immunogenetic profile of multiple sclerosis in Mexicans. Human Immunol. 16: 364-74
106. Moen, T., Stein, R., Bratlie, A., Bondevik, E. 1984. Distribution of HLA-SB antigens in multiple sclerosis. Tissue Antigens 4: 126-27
107. Odum, N., Hyldig-Nielsen, J. J., Morling, N., Sandberg-Wollheim, M., Platz, P., Svejgaard, A. 1988. HLA-DP antigens are involved in the susceptibility to multiple sclerosis. Tissue Antigens 31: 235-37
108. Cohen, D., Cohen, O., Marcadet, A., Massart, C., Lathrop, M., Deschamps, I., Hors, J., Schuller, E., Dausset, J. 1984. Class II HLA-DC β-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc. Natl. Acad. Sci. USA 81: 1774-78
109. Vartdal, F., Sollid, L. M., Vandvik, B., Markussen, G., Thorsby, E. 1989. Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequences. Hum. Immunol. 25: 103-10
110. Heard, R. N. S., Cullen, C., Middleton, D., Hawkins, S. A., Hern, J. E. C., McDonald, W. I., Batchelor, J. R., Lechler, R. I. 1989. An allelic cluster of DQα restriction fragments is associated with multiple sclerosis; evidence that a second haplotype may influence disease susceptibility. Hum. Immunol. 25: 111-23
111. Cowan, E. P., Pierce, M. L., McFarland, H. F., McFarlin, D. E. 1991. HLA-DR and -DQ allelic sequences in multiple sclerosis patients are identical to those found in the general population. Hum. Immunol. In press
112. Olerup, O., Hillert, J., Fredrikson, S., Olsson, T., Kam-Hansen, S., Moller, E., Carlsson, B., Wallin, J. 1989. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc. Natl. Acad. Sci. USA 86: 7113-17
113. Spurkland, A., Ronningen, K. S., Vandvik, B., Thorsby E., Vartdal, F. 1991. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. Hum. Immunol. 30: 69-75
114. Hammond, S. R., English, D., Dewtit, C., Maxwell, I. C., Milligen, J. S., Stewartwynne, E. G., McLeod, J. G., McCall, J. 1988. The clinical profile of MS in Australia. A comparison between medium-frequency and high-frequency prevalence zones. Neurology 38: 980-86
115. Beall, S. S., Concannon, P., Charmley, P., McFarland, H. F., Gatti, R. A., Hood, L. E., McFarlin, D. E., Biddison, W. E. 1989. The germline repertoire of T cell receptor β-chain genes in patient with chronic progressive multiple sclerosis. J. Neuroimmunol. 21: 59-66
116. Hillert, J., Leng, C., Olerup, O. 1991. No association with germline T cell receptor β-chain gene alleles or haplotypes in Swedish patients with multiple sclerosis. J. Neuroimmunol. 31: 141-47
117. Seboun, E., Robinson, M. A., Doolittle, T. H., Ciulla, T. A., Kindt, T. J., Hauser, S. L. 1989. A susceptibility locus for multiple sclerosis is linked to the T cell receptor β chain complex. Cell 57: 1095-1100
118. Oksenberg, J. R., Sherritt, M., Begovich, A. B., Erlich, H. A., Bernard, C. C., Cavalli-Sforza, L. L., Steinman, L. 1989. T-cell receptor Vα and Cα alleles associated with multiple sclerosis and myasthenia gravis. Proc. Natl. Acad. Sci. USA 86: 988-92
119. Olsson, T., Wei Zhi, W., Hojeberg, B., Kostulas, V., Yu-Ping, J., Anderson, G., Ekre, H.-P., Link, H. 1990. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ. J. Clin. Invest. 86: 981-85
120. Johnson, D., Hafler, D. A., Fallis, R. J., Lees, M. B., Brady, R. O., Quarles, R. H., Weiner, H. L. 1986. Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis. J. Neuroimmunol. 13: 99-108
121. Sun, J., Link, H., Olsson, T., Xiao, B.-G., Andersson, G. 1991. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146: 1490-95
122. Wood, D. D., Moscarello, M. A. 1989. The isolation, characterization, and lipid-aggregating properties of a citrulline containing myelin basic protein. J. Biol. Chem. 264: 5121-27
123. Burns, J., Rosenzweig, A., Zweiman, B., Lisak, R. P. 1983. Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell Immunol. 81: 435-40
124. Chou, Y. K., Offner, H., Bourdette, D. N., Whitham, R. H., Hashim, G., Vandenbark, A. A. 1991. Activated T-lymphocyte clones from the cerebrospinal fluid of multiple sclerosis patients preferentially recognize encephalitogenic myelin antigen. Neurology 41(Suppl. 1): 258
125. Ota, K., Matsui, M., Milford, E. L., Mackin, G. A., Weiner, H. L., Hafler, D. A. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346: 183-87
126. Allegretta, M., Nicklas, J. A., Sriram, S., Albertini, R. J. 1990. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247: 718-21
127. Richert, J. R., Robinson, E. D., Deibler, G. E., Martenson, R. E., Dragovic, L. J., Kies, M. W. 1989. Evidence for multiple human T cell recognition sites on myelin basic protein. J. Neuroimmunol. 23: 55-66
128. Richert, J. R., Robinson, E. D., Deibler, G. E., Martenson, R. E., Dragovic, L. J., Kies, M. W. 1989. Human cytotoxic T-cell recognition of a synthetic peptide of myelin basic protein. Ann. Neurol. 26: 342-46
129. Schluesener, H., Wekerle, H. 1985. Autoaggressive T lymphocyte lines recognize the encephalitogenic region of myelin basic protein; in vitro selection from unprimed rat T lymphocyte populations. J. Immunol. 135: 3128-33
130. Chou, Y. K., Vainiene, M., Whitham, R., Bourdette, D., Chou, CH., Hashim, G., Offner, H., Vandenbark, A. A. 1989. Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules. J. Neurosci. Res. 23: 207-16
131. Martin, R., Jaraquemada, D., Flerlage, M., Richert, J. R., Whitaker, J., Long, E. O., McFarlin, D. E., McFarland, H. F. 1990. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145: 540-48
132. Ando, D. G., Clayton, J., Kono, D., Urban, J. L., Sercarz, E. E. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124: 132-43
133. Pette, M., Fujita, K., Kitze, B., Whitaker, J. N., Albert, E., Kappos, L., Wekerle, H. 1990. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40: 1770-76
134. Pette, M., Fujita, K., Wilkinson, D., Altmann, D. M., Trowsdale, J., Giegerich, G., Hinkkanen, A., Epplen, J. T., Kappos, L., Wekerle, H. 1990. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 87: 7968-72
135. Martin, R., Howell, M. O., Jaraquemada, D., Flerlage, M., Richert, J. R., Brostoff, S., Long, E. O., McFarlin, D. E., McFarland, H. F. 1991. A myelin basic protein is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J. Exp. Med. 173: 19-24
136. Vandenbark, A. A., Hashim, G., Celnik, B., Galang, A., Li, X., Heber-Katz, E., Offner, H. 1989. Determinants of human myelin basic protein that induce encephalitogenic T cells in Lewis rats. J. Immunol. 143: 3512-16
137. Karkhanis, Y. D., Carlo, D. J., Brostoff, S. W., Eylar, E. H. 1975. Allergic encephalomyelitis: isolation of an encephalitogenic peptide active in the monkey. J. Biol. Chem. 250: 1718-22
138. Martin, R., Whitaker, J., Flerlage, M., Goodin, R. F., McFarlin, D. E., McFarland, H. F. 1991. T-cell recognition of a citrulline-containing myelin basic protein. Neurology 41(Suppl. 1): 257
139. Jaraquemada, D., Martin, R., Rosen-Bronson, S., Flerlage, M., McFarland, H. F., Long, E. O. 1990. HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. J. Immunol. 145: 2880-85
140. Sinigaglia, F., Guttinger, M., Kilgus, J., Doran, D. M., Matile, H., Etlinger, H., Trzeciak, A., Gillessen, D., Pink, J. R. L. 1988. A malaria T-cell epitope recognized in association with most mouse and human MHC-class II molecules. Nature 336: 778-70
141. Jacobson, S., Nepom, G. T., Richert, J. R., Biddison, W. E., McFarland, H. F. 1985. Identification of a specific HLA DR2 Ia molecule as a restriction element for measles virus-specific HLA class II-restricted cytotoxic T cell clones. J. Exp. Med. 161: 263-68
142. Wucherpfennig, K. W., Ota, K., Endo, N., Seidman, J. G., Rosenzweig, A., Weiner, H. L., Hafler, D. A. 1990. Shared human T cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science 248: 1016-19
143. Ben-Nun, A., Liblau, R. S., Cohen, L., Lehmann, D., Tournier-Lasserve, E., Rosenzweig, A., Jingwu, Z., Raus, J. C. M., Bach, M.-A. 1991. Restricted T-cell receptor Vβ gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis, predominant genes vary in individuals. Proc. Natl. Acad. Sci. USA 88: 2466-70
144. Richert, J. R., Robinson, E. D., Johnson, A. H., Bergman, C. A., Dragovic, L. J., Reinsmoen, N. L., Hurley, C. K. 1991. Heterogeneity of the T-cell receptor β gene rearrangements generated in myelin basic protein-specific T-cell clones isolated from a patient with multiple sclerosis. Ann. Neurol. 29: 299-306
145. Hafler, D. A., Keddy, C., Wucherpfennig, K. 1991. Analysis of T cell receptor Vα and Vβ structure for an immunodominant MBP peptide. FASEB J. 5: A1680
146. Richert, J., Robinson, E., Martin, R., McFarland, H. F., Horky, L., Yill, H., Hurley, C. K. 1991. Human T cell receptor (TCR) α and β gene expression in the response to myelin basic protein. FASEB J. 5: A1680
147. Oksenberg, J. R., Stuart, S., Begovich, A. B., Bell, R. B., Erlich, H. A., Steinman, L., Bernard, C. C. A. 1990. Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients. Nature 345: 344-46
148. Oksenberg, J. R., Panzara, M. A., Begovich, A. B., Erlich, H. A., Murray, R., Sherritt, M., Stuart, S., Bernard, C. C. A., Steinman, L. 1991. Restricted T cell receptor V gene rearrangements in multiple sclerosis brains of HLA-DRB1 1501, DQB1 0602 patients. Cell. Submitted
149. Wucherpfennig, K. W., Newcombe, J., Cuzner, L., Li, H., Keddy, C., Weiner, H. L., Hafler, D. A. 1991. Analysis of α/β and γ/δ T-cell receptors in MS plaques. Neurology 41(Suppl. 1): 257
150. Kurtzke, J. F. 1985. Epidemiology of multiple sclerosis. In Handbook of Clinical Neurology, ed. P. J. Vinken, G. W. Bruyn, H. L. Klawans, J. C. Koetsier, 3(47): 259-87. Amsterdam/New York: Elsevier Sci.
151. Kurtzke, J. F., Hyllestad, K. 1979. Multiple sclerosis in the Faroe Islands. Clinical and epidemiological features. Ann. Neurol. 5: 6-21
152. Martin, R., Ortlauf, J., Sticht-Groh, V., Bogdahn, U., Goldman, S. F., Mertens, H. G. 1988. Borrelia burgdorferi-specific and autoreactive T-cell lines from cerebrospinal fluid in Lyme radiculomyelitis. Ann. Neurol. 24: 509-16
153. Martin, R., Marquardt, P., O'Shea, S., Borkenstein, M., Kreth, H. W. 1989. Virus-specific and autoreactive T-cell lines isolated from cerebrospinal fluid of a patient with chronic rubella panencephalitis. J. Neuroimmunol. 23: 1-10
154. Whitaker, J. N. 1977. Myelin encephalitogenic protein fragments in cerebrospinal fluid of patients with multiple sclerosis. Neurology 27: 911-20
155. Fujinami, R. S., Oldstone, M. B. A. 1985. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230: 1043-45
156. Shaw, S.-Y., Laursen, R. A., Lees, M. B. 1986. Analogous amino acid sequences in myelin proteolipid and viral proteins. FEBS Lett. 207: 266-70
157. Crone, C. 1986. The blood-brain barrier: a modified type epithelium. In The Blood-Brain Barrier in Health and Disease, ed. A. J. Suckling, M. G. Rumsby, M. W. B. Bradbury, pp. 17-40. UK: E. Horwood
158. Head, J. R., Griffin, W. S. T. 1985. Functional capacity of solid tissue transplants in brain: evidence for immunological privilege. Proc. R. Soc. London Ser. B 224: 375-87
159. Kasik, J. W., Wan, Y. Y., Ozato, K. 1987. A burst of c-fos gene expression in the mouse occurs at birth. Mol. Cell. Biol. 7: 3349-57
160. McCarron, R. M., Spatz, M., Kempski, O., Hogan, R. N., Muehl, L., McFarlin, D. E. 1986. Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. J. Immunol. 137: 3428-35
161. Massa, P. T., Dorries, R., ter Meulen, V. 1986. Viral particles induce Ia antigen expression on astrocytes. Nature 320: 543-46
162. Wong, G. H. W., Clark-Lewis, J., Harris, A. W., Schrader, J. W. 1984. Effect of cloned interferon-gamma on expression of H-2 and Ia antigen on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin.
163. McCarron, R. M., Tanaka, M., Spatz, M. 1990. Class II major histocompatibility complex antigen expression in central nervous system: microglia, astrocytes and endothelial cells. In Pathophysiology of the Blood-Brain Barrier, ed. B. B. Johansson, C. O. Owman, H. Widner, pp. 467-84. Amsterdam/New York: Elsevier Sci.
164. Fontana, A., Fierz, W., Wekerle, H. 1984. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307: 273-76
165. Sun, D., Wekerle, H. 1986. Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature 320: 70-72
166. Dhib-Jalbut, S., Kufta, C. V., Flerlage, M., Shimojo, N., McFarland, H. F. 1990. Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells. J. Neuroimmunol. 29: 203-11
167. Cannella, B., Cross, A. H., Raine, C. S. 1990. Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J. Exp. Med. 172: 1521-24
168. Pober, S. J., Lapierre, L. A., Stolpeh, A. H., Brock, T. A., Springer, T. A., Fiers, W., Bevilacqua, M. P., Mendrich, D. L., Gimbrone, M. 1987. Activation of cultured endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin species. J. Immunol. 138: 3319-24
169. Selmaj, K., Raine, C. S. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23: 339-46
170. Powell, M. B., Mitchell, D., Lederman, J., Buchmeier, J., Zamvil, S. S., Graham, M., Ruddle, N. H., Steinman, L. 1990. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2: 539-44
171. Ruddle, N. H., Bergman, C. M., McGrath, K., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., Clark, R. B. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic enccphalomyelitis. J. Exp. Med. 172: 1193-1200